Ann: Quarterly Activities Report, page-5

In an ethical world, I agree with you. However, Jitto and Co are not ethical; and Medigen have a conflict of interest in seeing many TDL/TBG shareholders taking any profit, as Medigen benefit from charging for reagents and taking their profit that way, with none ending up with TDL/TBG holders who do not also own Medigen. It's corruption and we TDL/TBG holders will likely end up with shares worth zero. I have agitated with the ASX, including highlighting Jitto's previous form and the above CoI, and when my work slows down I'll ask a corporate lawyers view. Other than Jitto and Co being known for this behaviour (particularly by ASX...shit does stick), I'm expecting no solace.